Abstract:Abstract Many solid tumors have alterations in phosphoinositide 3-kinase (PI3K) signaling. These can occur through mutation of the p110alpha and p85alpha proteins of PI3Kalpha itself as well as through alterations to upstream receptor tyrosine kinases (RTKs) and phosphatases of PIP3, including PTEN. As a whole, PI3K signaling is one of the most frequently altered in cancer. These mutations lead to activation of the PI3K complex and to constitutive downstream signaling. This signaling allows cells to enter a pro-growth and pro-survival state which is beneficial to the cancer cells. The structure of PI3K has been extensively studied by crystallography and NMR. Here, we present our work on the full-length complex of p110alpha with p85alpha using cryo-EM. When compared with the previous structural studies, cryo-EM shows a similar structure and major structural features are unchanged. However, our cryo-EM studies revealed several additional structural features of the PI3K complex. Cryo-EM showed that SH3, BH and cSH2 domains of p85alpha can bind to p110alpha. When inhibited with Alpelisib, these domains form a stable cover of the active site of the kinase. These domains interact with the helical and kinase domains of p110alpha and the iSH2 domain of p85alpha. The position of these domains restricts access to the kinase active site and may contribute to the inhibition of PI3K activity by Alpelisib. When the PI3K complex binds to phosphorylated RTKs, the nSH2 binds to phosphotyrosine and relieves inhibitory interactions with the helical domain of p110alpha. Using cryo-EM, we have studied this activation by incubating the full-length PI3K complex with synthetic phosphopeptides. 2D cryo-EM class averages showed a dramatic rearrangement of the PI3K complex. In addition to the expected displacement of the nSH2 domain, the ABD and iSH2 domains undergo structural changes. Acknowledgments: This work was supported by the National Cancer Institute of the National Institutes of Health under awards R35 CA197582 (PKV) and R50 CA243899 (JRH). Citation Format: Jonathan R. Hart, Su Yang, Xiao Liu, Yingna Xu, Xinyu Zou, Huibing Zhang, Qingtong Zhou, Tian Xia, Yan Zhang, Dehua Yang, Ming-Wei Wang, Peter K. Vogt. Cryo-electronmicroscopy of PI3K reveals additional regulatory features [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 671.

Cryo-EM of AKAP350 reveals fibrillar clusters and a potential association with DNA

Cryo-EM structure of the DNA-PK holoenzyme.

Cryo-EM structures of PI3K reveal conformational changes during inhibition and activation

Cryo-EM Structure of Human DNA-PK Holoenzyme

Abstract 671: Cryo-electronmicroscopy of PI3K Reveals Additional Regulatory Features

A Novel Cryo-Electron Microscopy Support Film Based on 2D Crystal of HFBI Protein

Cryo‐EM of Dynamic Protein Complexes in Eukaryotic DNA Replication

Étude Structurale De Deux Complexes Macromoléculaires Biologiques : FANCD2/FANCI Et La Phosphorylase Kinase Par Cryo Microscopie Électronique

Structure of an activated DNA-PK and its implications for NHEJ

Cryo-EM Structure of Human ATR-ATRIP Complex

Structural analysis of the basal state of the Artemis:DNA-PKcs complex

The crystal structure of the RhoA–AKAP-Lbc DH–PH domain complex

Cryo-EM Structure of AAA + ATPase Thorase Reveals Novel Helical Filament Formation

Cryo-EM visualization of DNA-PKcs structural intermediates in NHEJ

The cryo-EM structure of ASK1 reveals an asymmetric architecture allosterically modulated by TRX1

The Crystal Structure of Human Adenylate Kinase 6: an Adenylate Kinase Localized to the Cell Nucleus

Stretch and Twist of HEAT Repeats Leads to Activation of DNA-PK Kinase

Single-particle cryo-EM at atomic resolution

¹H, ¹³C, ¹⁵N backbone and side-chain resonance assignments of the human adenylate kinase 1 in apo form.

Structural analyses of the PKA RII holoenzyme containing the oncogenic DnaJB1-PKAc fusion protein reveal protomer asymmetry and fusion-induced allosteric perturbations in fibrolamellar hepatocellular carcinoma